Thrivent Financial For Lutherans Bristol Myers Squibb CO Transaction History

Thrivent Financial For Lutherans

  • $49.6 Billion
  • Q2 2024

A detailed history of Thrivent Financial For Lutherans transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 111,394 shares of BMY stock, worth $5.93 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
111,394
Previous 123,843 10.05%
Holding current value
$5.93 Million
Previous $6.72 Million 31.13%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
SELL
$40.25 - $52.99 $501,072 - $659,672
-12,449 Reduced 10.05%
111,394 $4.63 Million
Q1 2024

May 14, 2024
SELL
$47.98 - $54.4 $4.24 Million - $4.81 Million
-88,420 Reduced 41.66%
123,843 $6.72 Million
Q4 2023

Feb 14, 2024
SELL
$48.48 - $57.85 $1.9 Million - $2.27 Million
-39,279 Reduced 15.62%
212,263 $10.9 Million
Q3 2023

Nov 14, 2023
SELL
$57.89 - $64.73 $3.49 Million - $3.91 Million
-60,360 Reduced 19.35%
251,542 $14.6 Million
Q2 2023

Aug 14, 2023
SELL
$63.71 - $70.74 $1.13 Million - $1.26 Million
-17,789 Reduced 5.4%
311,902 $19.9 Million
Q1 2023

May 17, 2023
BUY
$65.71 - $74.53 $104,610 - $118,651
1,592 Added 0.49%
329,691 $22.8 Million
Q4 2022

Feb 08, 2023
BUY
$68.48 - $81.09 $13.2 Million - $15.6 Million
192,969 Added 142.8%
328,099 $23.6 Million
Q3 2022

Nov 14, 2022
SELL
$0.13 - $76.84 $84 - $49,792
-648 Reduced 0.48%
135,130 $9.61 Million
Q2 2022

Aug 16, 2022
SELL
$72.62 - $79.98 $1.59 Million - $1.75 Million
-21,890 Reduced 13.88%
135,778 $10.5 Million
Q1 2022

May 13, 2022
BUY
$61.48 - $73.72 $231,164 - $277,187
3,760 Added 2.44%
157,668 $11.4 Million
Q4 2021

Feb 16, 2022
BUY
$53.63 - $62.52 $303,921 - $354,300
5,667 Added 3.82%
153,908 $9.77 Million
Q3 2021

Nov 15, 2021
BUY
$59.17 - $69.31 $469,099 - $549,489
7,928 Added 5.65%
148,241 $8.87 Million
Q2 2021

Sep 24, 2021
BUY
$61.91 - $67.42 $1.58 Million - $1.72 Million
25,489 Added 22.2%
140,313 $9.38 Million
Q2 2021

Aug 19, 2021
SELL
$61.91 - $67.42 $1.58 Million - $1.72 Million
-25,561 Reduced 18.21%
114,824 $7.67 Million
Q1 2021

May 17, 2021
BUY
$59.34 - $66.74 $399,417 - $449,226
6,731 Added 5.04%
140,385 $8.86 Million
Q4 2020

Feb 16, 2021
BUY
$57.74 - $65.43 $236,272 - $267,739
4,092 Added 3.16%
133,654 $8.29 Million
Q3 2020

Nov 10, 2020
BUY
$57.43 - $63.64 $670,495 - $742,997
11,675 Added 9.9%
129,562 $7.81 Million
Q2 2020

Aug 12, 2020
SELL
$54.82 - $64.09 $120,604 - $140,998
-2,200 Reduced 1.83%
117,887 $6.88 Million
Q1 2020

May 15, 2020
SELL
$46.4 - $67.43 $155,208 - $225,553
-3,345 Reduced 2.71%
120,087 $6.68 Million
Q4 2019

Feb 13, 2020
BUY
$49.21 - $64.19 $1.82 Million - $2.37 Million
36,977 Added 42.77%
123,432 $7.92 Million
Q3 2019

Nov 14, 2019
BUY
$42.77 - $50.71 $260,340 - $308,671
6,087 Added 7.57%
86,455 $4.38 Million
Q2 2019

Aug 13, 2019
SELL
$44.62 - $49.34 $3.37 Million - $3.73 Million
-75,539 Reduced 48.45%
80,368 $3.65 Million
Q1 2019

May 14, 2019
SELL
$45.12 - $53.8 $539,229 - $642,963
-11,951 Reduced 7.12%
155,907 $7.44 Million
Q4 2018

Feb 15, 2019
BUY
$48.76 - $63.23 $4.23 Million - $5.48 Million
86,738 Added 106.93%
167,858 $8.84 Million
Q3 2018

Nov 15, 2018
BUY
$55.19 - $62.25 $74,948 - $84,535
1,358 Added 1.7%
81,120 $5.04 Million
Q2 2018

Aug 14, 2018
SELL
$50.53 - $62.98 $18,342 - $22,861
-363 Reduced 0.45%
79,762 $4.41 Million
Q1 2018

May 08, 2018
SELL
$59.92 - $68.98 $68,488 - $78,844
-1,143 Reduced 1.41%
80,125 $5.07 Million
Q4 2017

Feb 14, 2018
BUY
$59.94 - $65.35 $202,777 - $221,079
3,383 Added 4.34%
81,268 $4.98 Million
Q3 2017

Nov 14, 2017
BUY
$55.23 - $63.74 $4.3 Million - $4.96 Million
77,885
77,885 $4.96 Million

Others Institutions Holding BMY

# of Institutions
2,428
Shares Held
1.5B
Call Options Held
29.7M
Put Options Held
32.2M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Thrivent Financial For Lutherans Portfolio

Follow Thrivent Financial For Lutherans and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email